New surprises of suppressor of cytokine signalling in liver fibrosis

被引：7
作者：
Cheng, Chang [1 ,2 ]
Huang, Cheng [1 ,2 ]
Ma, Tao-Tao [1 ,2 ]
Xu, Tao [1 ,2 ]
Wang, Ya-Rui [1 ,2 ]
Zhang, Lei [1 ,2 ]
Jun, Li [1 ,2 ]
机构：
[1] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Inst Liver Dis, Hefei 230032, Anhui, Peoples R China
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2014年 / 18卷 / 04期
基金：
美国国家科学基金会;
关键词：
epigenetics; liver fibrosis; macrophages; suppressor of cytokine signalling; target; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; SOCS PROTEINS; GENE-EXPRESSION; NEGATIVE REGULATOR; DNA METHYLATION; INNATE IMMUNITY; TGF-BETA; GROWTH; INFLAMMATION;
D O I：
10.1517/14728222.2014.885953
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Introduction: Liver fibrosis is a progressive condition with serious clinical complications arising from abnormal proliferation and amassing of tough fibrous scar tissue. Macrophages are found in secreting chemokines that recruit fibroblasts and other inflammatory cells, and inflammatory cytokines that activate the hepatic stellate cell (HSC) play an essential event during liver fibrogenesis. The potential of macrophages acts in both pro- and anti-fibrotic capacities followed by related genes of inflammation in coordination with epigenetic modifications in liver fibrogenesis. Areas covered: In this review, we focus on the role of suppressor of cytokine signalling (SOCS) proteins in transcriptional regulation at the level of the chromatin structure and the interaction of SOCS with microRNAs during liver fibrosis. Moreover, we will discuss the different signalling pathways that interact with SOCS-regulated HSC activation. Expert opinion: Although the exact role of SOCS proteins in liver fibrosis has not been fully elucidated, recognition of SOCS proteins and its regulation by these multiple mechanisms may offer new potential targets of liver fibrosis, and provide new understandings of the development of future therapeutic strategies.
引用
收藏
页码：415 / 426
页数：12
相关论文
共 81 条
  • [41] Epigenetic regulation of hepatic stellate cell activation
    Mann, Derek A.
    Mann, Jelena
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : S108 - S111
  • [42] Matsukawa A, 2007, ACTA MED OKAYAMA, V61, P239
  • [43] Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma
    Niwa, Y
    Kanda, H
    Shikauchi, Y
    Saiura, A
    Matsubara, K
    Kitagawa, T
    Yamamoto, J
    Kubo, T
    Yoshikawa, H
    [J]. ONCOGENE, 2005, 24 (42) : 6406 - 6417
  • [44] MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
    O'Connell, Ryan M.
    Kahn, Daniel
    Gibson, William S. J.
    Round, June L.
    Scholz, Rebecca L.
    Chaudhuri, Aadel A.
    Kahn, Melissa E.
    Rao, Dinesh S.
    Baltimore, David
    [J]. IMMUNITY, 2010, 33 (04) : 607 - 619
  • [45] Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
    Ogata, H
    Chinen, T
    Yoshida, T
    Kinjyo, I
    Takaesu, G
    Shiraishi, H
    Iida, M
    Kobayashi, T
    Yoshimura, A
    [J]. ONCOGENE, 2006, 25 (17) : 2520 - 2530
  • [46] Immunohistochemical distribution of activated nuclear factor κB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats
    Orfila, C
    Lepert, JC
    Alric, L
    Carrera, G
    Béraud, M
    Pipy, B
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 2005, 123 (06) : 585 - 593
  • [47] Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice
    Palacios, Rebeca Salguero
    Roderfeld, Martin
    Hemmann, Stefanie
    Rath, Timo
    Atanasova, Srebrena
    Tschuschner, Annette
    Gressner, Olav A.
    Weiskirchen, Ralf
    Graf, Juergen
    Roeb, Elke
    [J]. LABORATORY INVESTIGATION, 2008, 88 (11) : 1192 - 1203
  • [48] Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function
    Palmer, Douglas C.
    Restifo, Nicholas P.
    [J]. TRENDS IN IMMUNOLOGY, 2009, 30 (12) : 592 - 602
  • [49] Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment
    Phan, Vernon T.
    Wu, Xiumin
    Cheng, Jason H.
    Sheng, Rebecca X.
    Chung, Alicia S.
    Zhuang, Guanglei
    Tran, Christopher
    Song, Qinghua
    Kowanetz, Marcin
    Sambrone, Amy
    Tan, Martha
    Meng, Y. Gloria
    Jackson, Erica L.
    Peale, Franklin V.
    Junttila, Melissa R.
    Ferrara, Napoleone
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (15) : 6079 - 6084
  • [50] Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
    Pogribny, Igor P.
    Starlard-Davenport, Athena
    Tryndyak, Volodymyr P.
    Han, Tao
    Ross, Sharon A.
    Rusyn, Ivan
    Beland, Frederick A.
    [J]. LABORATORY INVESTIGATION, 2010, 90 (10) : 1437 - 1446
123456789